PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,000 | -100.0% | 255 | -100.0% | 0.00% | -100.0% |
Q4 2015 | $3,141,000 | -39.5% | 887,214 | -14.0% | 0.53% | -32.1% |
Q3 2015 | $5,189,000 | -22.2% | 1,031,540 | -0.6% | 0.78% | -18.8% |
Q2 2015 | $6,672,000 | -15.3% | 1,037,600 | -7.3% | 0.97% | -5.0% |
Q1 2015 | $7,878,000 | -7.8% | 1,119,794 | +1.1% | 1.02% | -11.0% |
Q4 2014 | $8,540,000 | -11.9% | 1,107,698 | -14.7% | 1.14% | -10.8% |
Q3 2014 | $9,699,000 | – | 1,298,459 | – | 1.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
Leap Investments LP | 69,496 | $150,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |